MEK Inhibitor News and Research

RSS
BeiGene collaborates with SpringWorks to evaluate new combinational therapy for solid tumors

BeiGene collaborates with SpringWorks to evaluate new combinational therapy for solid tumors

Novartis' new drug combination receives positive CHMP opinion for treating stage III BRAF mutant melanoma

Novartis' new drug combination receives positive CHMP opinion for treating stage III BRAF mutant melanoma

New avenue for cancer treatment opens when one drug fails

New avenue for cancer treatment opens when one drug fails

Changing schedules of targeted therapy for melanoma could improve outcomes

Changing schedules of targeted therapy for melanoma could improve outcomes

Study reports longer survival for obese men with metastatic melanoma

Study reports longer survival for obese men with metastatic melanoma

Pretreatment improves outcomes in high-risk stage 3 melanoma, study shows

Pretreatment improves outcomes in high-risk stage 3 melanoma, study shows

Treatment for skin cancer could be more effective if combined with arthritis drug

Treatment for skin cancer could be more effective if combined with arthritis drug

Combination therapy found to be effective adjuvant treatment option in melanoma patients

Combination therapy found to be effective adjuvant treatment option in melanoma patients

Combination therapy shows potential for effective treatment of RAS-mutant cancers

Combination therapy shows potential for effective treatment of RAS-mutant cancers

KRAS ‘imbalances’ that emerge over time may influence cancer treatment response

KRAS ‘imbalances’ that emerge over time may influence cancer treatment response

Scientists discover how MEK inhibitor boosts antitumor activity and slows cancer progression

Scientists discover how MEK inhibitor boosts antitumor activity and slows cancer progression

Researchers identify existing drugs that appear to prevent aggressive subtype of pediatric brain tumors

Researchers identify existing drugs that appear to prevent aggressive subtype of pediatric brain tumors

Researchers report high response rate with single drug in phase I/II trial of paediatric brain cancer

Researchers report high response rate with single drug in phase I/II trial of paediatric brain cancer

Immune and targeted therapies may be beneficial in patients with melanoma brain metastases

Immune and targeted therapies may be beneficial in patients with melanoma brain metastases

Researcher identifies mechanisms that may cause resistance to BRAF inhibitor

Researcher identifies mechanisms that may cause resistance to BRAF inhibitor

Breakthrough in cancer cell screening advances personalised treatment of childhood leukaemia

Breakthrough in cancer cell screening advances personalised treatment of childhood leukaemia

Targeted therapies suppress T cell activity that could actually help fight tumors

Targeted therapies suppress T cell activity that could actually help fight tumors

Wistar Institute scientists use revolutionary method to block melanoma progression

Wistar Institute scientists use revolutionary method to block melanoma progression

CU Cancer Center study reports 'robust antitumor activity' of TAK-733 drug in mouse models of colorectal cancer

CU Cancer Center study reports 'robust antitumor activity' of TAK-733 drug in mouse models of colorectal cancer

2-year advanced melanoma survival benefit with dabrafenib, trametinib combination

2-year advanced melanoma survival benefit with dabrafenib, trametinib combination